Transvaginal Mesh Lawsuit
Transvaginal mesh is a product used by women to relieve pain as well as alleviate bowel and bladder issues associated with conditions like pelvic organ prolapse and stress urinary incontinence.
Unfortunately, these products have been linked to serious, life-threatening side effects.
Common Vaginal Mesh Products
Transvaginal mesh is used for women who suffer from Pelvic Organ Prolapse (POP) or Stress Urinary Incontinence (SUI). These are characterized by the dropping of the bladder, uterus, bowel and/or rectum of a woman, resulting in the organ pushing against the wall of the woman’s vagina. This usually occurs in women who have had vaginal births or have undergone surgeries that caused their pelvic muscles to lose strength.
Mesh products were produced in order to relieve pain as well as to alleviate bowel and bladder issues associated with POP and SUI.
It’s important to note that there are a number of vaginal products that have promoted and sold to hospitals, medical staff and facilities, with some of these items potentially causing serious personal injury.
This list includes:
|Tyco IVS Tunneller||Gynecare Prolift||Prolift mtm|
|Tvt Secure||Prosima||Caldera T-Sling|
|Caldera Desara Pelvis Mesh||Coloplast||Avulta|
|Bard Pelvisoft||Bard Pelvilace|
FDA Mesh Warnings
In 2008, the Food and Drug Administration (FDA) issued its first warning about transvaginal mesh complications. The public health notification was released following thousands of reports of transvaginal mesh complications received by the agency over a three year period. The FDA mesh warnings described complications that included mesh erosion, pain, infection and more.
Following the public health notification in 2008, the FDA issued a report on July 13, 2011 with the following warnings:
- Complications with transvaginal mesh are NOT rare.
- There is no evidence that procedures involving mesh repair are more effective than non-mesh procedures.
- The use of transvaginal mesh exposes patients to more unnecessary risk.
Despite the FDA mesh warnings in 2008, manufacturers continued to produce this product and put women at risk of serious side effects. Between 2008 and 2010, the agency received more than 1,500 reports of mesh complications – five times as many as were received between 2005 and 2007.
Transvaginal Mesh Complications
Some of the most common transvaginal mesh complications reported to the FDA include:
- Erosion of mesh into the vagina.
- Pain during sex caused by vaginal scarring and mesh erosion.
- Recurrence of prolapsed organs.
- Urinary problems.
- Damage to bladder, bowel and blood vessels.
- Emotional and mental trauma.
A majority of transvaginal mesh complications have led to the removal of the mesh and additional surgeries, including IV therapy, blood transfusions and drainage of hematomas or abscesses.